Abstract
Introduction
A fetal anomaly scan in mid-pregnancy is performed, to check for the presence of congenital anomalies, including congenital heart disease (CHD). Unfortunately, 40% of CHD is still missed. The combined use of ultrasound and electrocardiography might boost detection rates. The electrical heart axis is one of the characteristics which can be deduced from an electrocardiogram (ECG). The aim of this study was to determine reference values for the electrical heart axis in healthy fetuses around 20 weeks of gestation.
Material and methods
Non-invasive fetal electrocardiography was performed subsequent to the fetal anomaly scan in pregnant women carrying a healthy singleton fetus between 18 and 24 weeks of gestation. Eight adhesive electrodes were applied on the maternal abdomen including one ground and one reference electrode, yielding six channels of bipolar electrophysiological measurements. After removal of interferences, a fetal vectorcardiogram was calculated and then corrected for fetal orientation. The orientation of the electrical heart axis was determined from this normalized fetal vectorcardiogram. Descriptive statistics were used on normalized cartesian coordinates to determine the average electrical heart axis in the frontal plane. Furthermore, 90% prediction intervals (PI) for abnormality were calculated.
Results
Of the 328 fetal ECGs performed, 281 were included in the analysis. The average electrical heart axis in the frontal plane was determined at 122.7° (90% PI: -25.6°; 270.9°).
Discussion
The average electrical heart axis of healthy fetuses around mid-gestation is oriented to the right, which is, due to the unique fetal circulation, in line with muscle distribution in the fetal heart.
Introduction
In developed countries a fetal anomaly scan in mid-pregnancy is performed to check for the presence of congenital anomalies, including congenital heart disease (CHD). The importance of prenatal CHD detection has been highlighted by was previous research that found a reduction in neonatal morbidity and mortality when CHD was diagnosed prenatally [1, 2]. The introduction of a standardized screening program for the fetal anomaly scan in mid-pregnancy has led to an increase in prenatal CHD detection rates in the Netherlands up to 40–60%. However, 40% of CHD is still missed [3]. Ultrasound detection of CHD is difficult due to fetal body movements, and the small size and rhythmic movements of the fetal heart. Furthermore, detection rates depend on the experience of the sonographer, fetal position and BMI of the mother [4–13]. New diagnostic tools are needed to further increase the prenatal detection of CHD.
A tool might be the non-invasive fetal electrocardiogram (NI-fECG). NI-fECG enables the production of a 12-lead electrocardiogram by means of a standardized method [14]. ST-segment elevations are seen in ischemia and deviation of the electrical heart axis occurs in some cardiac malformations (e.g. hypoplastic right heart syndrome, atrioventricular septal defect) [15–17]. The electrical heart axis is one of the characteristics which can be deduced from an ECG. It represents the median vector of the electrical activity through the heart during one cardiac cycle and provides information about the muscle distribution of the heart.
Verdurmen et al. found a right-oriented electrical heart axis in healthy fetuses [18]. This has also been described in term fetuses during labor and in neonates [19, 20]. The right-oriented electrical heart axis in healthy fetuses can be explained by the fetal circulation that has a unique physiology with multiple shunts to bypass the lungs, so that the right ventricle pumps 60% of the cardiac output, leading to a right ventricular dominance. After birth the pulmonary vascular resistance drops and the venous return to the left atrium increases leading to an increase in the cardiac output of the left ventricle. The left ventricle pumps against the high resistance systemic system once the placental circulation is eliminated [21]. With time the left ventricular muscle mass gradually increases and a leftwards shift of the electrical heart axis occurs. We hypothesize that the presence of certain CHD can already cause a deviated electrical heart axis in utero.
The aim of this paper was to determine reference values for the electrical heart axis in mid-term healthy fetuses.
Materials and methods
The study protocol was previously published by Verdurmen et al. [22] Ethical approval by the institutional review board of the Máxima Medical Center was obtained before enrolment (NL48535.015.14). Fetal ECG measurements were performed from May 2014 until September 2018 at the Máxima Medical Centre Veldhoven, The Netherlands, a tertiary care referral center for obstetrics and at ‘Diagnostiek voor U’ diagnostic center, Eindhoven, The Netherlands.
Study population
Pregnant women carrying a singleton fetus without known congenital anomalies and a gestational age between 18 and 24 weeks of gestation were included. All patients were older than 18 years and gave written informed consent prior to the fetal ECG measurement.
Patients who did not understand the Dutch language well and/or had multiple pregnancies were excluded. If CHD was found later in pregnancy or after birth, the measurement was excluded from analysis.
The following data was gained prospectively: maternal gravidity and parity, as well as obstetric and general medical history. Parents received a questionnaire three months after birth to confirm that the child was healthy and did not have any congenital diseases. We chose this three-month cut-off point as at this age, all children in the Netherlands have had their second medical check-up by a doctor, who, among other things, evaluates cardiac health using auscultation.
fECG measurements and signal processing
Singular fetal ECG measurements were performed subsequent to the fetal anomaly scan. Women lay in a semi-recumbent position to prevent aortocaval compression. To yield six channels of bipolar electrophysiological measurements, eight electrodes were placed on the maternal abdomen in a fixed configuration. Two electrodes served as common reference and ground electrodes respectively (Fig 1; [23]). Before application of the electrodes the skin was washed with water and soap after which skin preparation was performed with medical abrasive paper (Red DotTM Trace Prep, 3M Health Care, Ontario, Canada) to optimize skin impedance. Each measurement lasted around 30 minutes during which fetal orientation was ultrasonographically checked at four fixed time intervals. After training by an experienced gynecologist or sonographer the researcher determined the fetal orientation by ultrasound. The fetal orientation was determined following a step-by-step plan in which the spine was taken as an identifiable landmark. The ultrasound probe was held only in a horizontal and/or vertical position for it to be reproducible and annotations were made about the position of the probe. To evaluate the accuracy of our orientation correction, the correct ECGs/VCGs of a single participant are compared to verify their consistency.
Fetal ECG measurements were performed with a 6-channel electrophysiological amplifier (Nemo Healthcare BV, The Netherlands) using adhesive Ag/AgCl electrodes (Red DotTM, 3M Health Care, Ontario, Canada) on the maternal abdomen. The measured electrophysiological signals were digitized at 500 Hz sampling frequency and stored on a computer for offline analysis.
This offline analysis consisted of a series of signal processing steps, aimed to suppress interferences and standardize the fetal ECG signals for fetal orientation, so that the fetal electrical heart axis could be measured. These signal processing steps have been described in more detail in Lempersz et al. 2020 [23]. In the first step of signal processing, interferences from the maternal ECG, abdominal muscles, and extracorporal sources were suppressed by an adaptive template-based method [24]. As a result, for each of the six recorded signals a fetal ECG signal was obtained, yet at relatively low signal-to-noise ratio. Because each fetus could have a different orientation with respect to the maternal abdomen and the recording electrodes placed on this abdomen, the fetal ECG signals not only changed between participants, but also within participants due to fetal movement.
The second step in the signal processing aimed to standardize for fetal orientation. To allow for such standardization, a fetal vectorcardiogram was calculated for every heartbeat first, combining the information from the six abdominal signals into a 3-dimensional fetal ECG complex [25]. This vectorcardiogram could subsequently be tracked over time, detecting fetal movements and correcting for them by rotating the fetal vectorcardiogram in 3-dimensional space. Finally, another rotation in 3-dimensional space was applied that corrected for the fetal orientation, which was assessed from intermittent ultrasound scans. For instance, if the ultrasound indicated that the fetus was in a cephalic position, the recorded fetal vectorcardiogram was rotated by 180 degrees to represent the fetal vectorcardiogram as if the fetus was in a breech position, mimicking the position used when making adult ECGs. Similarly, the fetus was rotated along the longitudinal axis as if the fetal back was orientated towards the back of the mother. The parts of the measurements of sufficient signal quality, closest to the performance of the ultrasound determining fetal orientation, were used to create the vectorcardiogram.
Finally, to enhance the signal-to-noise ratio, orientation-standardized fetal vectorcardiograms were averaged over multiple heartbeats to yield one fetal vectorcardiogram per measurement.
The orientation of the electrical heart axis was defined as the direction in which the vectorcardiogram had its maximum amplitude [25]. The latter direction was estimated as the average direction of the dominant vectors in the QRS complex, defined as the vectors from the point that the R-wave exceeded 70% of its maximum value until the point that it fell below 70% of the maximum value. The orientation of the fetal heart axis was expressed in degrees ranging from minus 180° to plus 180° and calculated in the frontal plane, where minus 90° is located superiorly.
Statistical analysis
The observed frontal angle was determined in the (x,y)-plane. The normalized coordinates () were calculated as the division of the originate coordinates (x, y) by their Euclidean norm .
We calculated descriptive statistics (median with interquartile range (IQR)) on the normalized () Cartesian coordinates. We also reported the average frontal axis with 90% prediction intervals that would function as reference values. Prediction intervals are chosen because they account for the uncertainty in estimating the population mean and the random variation of the individual values [26]. The average frontal axis is a circular mean, therefore the maximum likelihood estimate (mle) of the mean direction parameter μ of a von Mises distribution will be used as the average frontal axis.
The prediction intervals were calculated, using the lower and upper quantiles of the Von Mises distribution with the estimated parameters.
Statistical analysis was conducted with SAS (version 9.4, SAS Institute Inc., NC, USA) and R (version 3.5.3, R Foundation, Vienna, Austria). Descriptive statistics (median with interquartile ranges) were used to describe baseline characteristics, using IBM SPSS statistics version 25.0 (SPSS Inc., Chicago, Ill., USA).
Data are available upon request.
Results
A total of 328 patients were included. From these, 15 measurements were excluded due to missing or incomplete questionnaires and 23 measurements were excluded due to missing information on the fetal orientation. CHD was found in one neonate and a chromosomal disorder was present in three neonates as reported in the postpartum questionnaire, necessitating their exclusion. Of the remaining 286 inclusions (87.2% of the original 328 included patients), five measurements had to be excluded due to poor quality NI-fECG recordings. A total of 281/286 measurements were available for further analysis giving a success rate of 98%. Table 1 shows the characteristics of the study population. Fig 2 shows a flowchart of the included measurements.
Table 1. Baseline characteristics of participants (N = 281).
Mean (± SD) | |
---|---|
Age (years) | 31.3 (± 4.0) |
GA (weeks) | 20.2 (± 1.3) |
Nulliparous (%) | 52.3 |
BMI (kg/m 2 ) | 24.4 (± 5.4) |
Abbreviations: GA = gestational age, BMI = body mass index.
Fig 3 is an example of a fetal electrocardiogram, here one can see a clear QRS-complex.
The median and interquartile range (IQR) of the coordinate was 0.347 (1.660) and that of the coordinate was 0.327 (0.956). Based on these normalized coordinates, the average frontal angle was determined at 122.68° (90% PI: -25.6°; 270.9°). Fig 4 shows the distribution of the orientation of the electrical heart axis of each fetus. The arrow shows the mean electrical heart axis with, in grey, corresponding 90% PI in the frontal plane.
Discussion
Main findings
In this paper we present reference values for the electrical heart axis calculated from our cohort of 281 healthy fetuses at mid-gestation. We found the mean electrical heart axis of the healthy fetus orientated to the right (122.68°), which is in line with the distribution of fetal cardiac muscle mass due to the unique anatomy of the fetal circulatory system and findings from previous studies [17–20, 27]. We found that the prediction intervals based on our cohort are wide, indicating a broad range wherein future observations will fall.
Strengths and limitations
The main strength of this study is the large group of participants and the low number of recordings excluded due to inadequate data quality. The latter shows that this technology has improved significantly compared to earlier reported research [28–30]. This high success rate is an indispensable characteristic for any technology to be implemented in daily practice. However, the time needed to process the recordings is at this moment the limiting factor for the NI-fECG technology, which currently still takes place offline. Therefore, results are not yet readily available during the measurement. This can be solved by automatization of the signal processing algorithms in the future which can then be incorporated in the measurement hardware. Furthermore, a few factors can contribute to inaccuracies in the correction for the fetal orientation; inaccuracies in the correction for the fetal movement and inaccurate assessment of the fetal orientation and the time at which this assessment was made. To minimize these inaccuracies, we have used the ECG data that was recorded around the time that the fetal orientation assessment was done. Possible cumulative errors in the correction for movement will therefore be limited. As an extra check, the fetal orientation was determined multiple times per recording. Within a single patient, the correct ECGs/VCGs are compared to verify their consistency, which can act as an indirect evaluation of the accuracy of our orientation correction.
Interpretation
To our knowledge, this is the first study that determines reference values for the electrical heart axis in healthy midterm fetuses. Recent advances in the signal processing algorithms have made it possible to acquire information on the fetal ECG in the antenatal period in a non-invasive manner. This makes it possible to define reference values for the electrical heart axis in healthy fetuses in mid-pregnancy.
The electrical heart axis reflects the distribution of muscle mass in the fetal heart. In the fetal circulation with its three obligatory shunts and the high resistance pulmonary and low resistance systemic circulations, the right ventricle is dominant and pumps about 60% of the cardiac output. As a consequence the muscle mass of the right ventricle is greater than that of the left ventricle and this results in greater amplitude of depolarization together with decreased speed of depolarization on the right side [31]. Our results confirm this right oriented electrical heart axis in healthy fetuses. The next step towards determining the use of this parameter for screening purposes is to define the electrical heart axis in fetuses with CHD.
Fetal electrocardiography is an easy to use, non-invasive, safe technology with a minimal burden for the pregnant women. Further research towards the electrical heart axis in fetuses with different types of CHD is necessary to determine which defects are associated with a deviated fetal electrical heart axis. Then the NI-fECG could be performed in addition to the fetal anomaly scan around the 20th week of gestation as part of prenatal screening after automatization of the signal processing of the recording. A point of attention is the broad distribution of the electrical heart axis found in our cohort of healthy fetuses in mid-pregnancy. This resulted in wide predictions intervals [-25.6°; 270.9°] making the use of the electrical heart axis alone as a parameter for the screening of CHD less suitable. Future research towards ECG waveform and ECG intervals may add to the development of additional ECG parameters which could further enhance the prenatal detection of CHD.
Conclusion
Our results confirm that the mean electrical heart axis of healthy fetuses around mid-gestation is oriented to the right. The wide prediction interval for the frontal heart axis found in our cohort, is unfavorable for future implementation of this method for screening purposes. Further research towards the electrical heart axis in fetuses with CHD as well as additional ECG waveform and intervals may elucidate the role of fetal ECG as a screening parameter for the detection of CHD.
Supporting information
Acknowledgments
The authors would like to express their gratitude to ´Diagnostiek voor U´ diagnostic center, (Eindhoven, The Netherlands), N. Eijsvoogel, D. Aben, O. Hulsenboom, M. Sengers, J. Drinkwaard, C. van den Oord, M. van Wierst, L. Cornelissen, C. de Vet and M. van Bruggen for their cooperation and effort towards the recruitment of patients and their role in the data collection.
Data Availability
Data cannot be shared publicly because this was not included in the informed consent procedure participants signed for. Data are available from the Máxima Medical Center Institutional Data Access (contact via jolanda.luime@mmc.nl) for researchers who meet the criteria for access to confidential data.
Funding Statement
This research was supported by The Dutch Technology Foundation STW (#12470), Stichting de Weijerhorst, Horizon2020 (#719500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Cloete E, Bloomfield FH, Sadler L, de Laat MWM, Finucane AK, Gentles TL. Antenatal Detection of Treatable Critical Congenital Heart Disease Is Associated with Lower Morbidity and Mortality. J Pediatr. 2019;204:66–70. doi: 10.1016/j.jpeds.2018.08.056 [DOI] [PubMed] [Google Scholar]
- 2.Brown KL, Ridout DA, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart. 2006;92(9):1298–302. doi: 10.1136/hrt.2005.078097 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.van Velzen CL, Clur SA, Rijlaarsdam MEB, Bax CJ, Pajkrt E, Heymans MW, et al. Prenatal detection of congenital heart disease—results of a national screening programme. BJOG. 2016. Feb;123(3):400–7. doi: 10.1111/1471-0528.13274 [DOI] [PubMed] [Google Scholar]
- 4.Allan L. Fetal cardiac scanning today. Prenat Diagn. 2010. Jul;30(7):639–43. doi: 10.1002/pd.2540 [DOI] [PubMed] [Google Scholar]
- 5.DeVore GR, Medearis AL, Bear MB, Horenstein J, Platt LD. Fetal echocardiography: factors that influence imaging of the fetal heart during the second trimester of pregnancy. J Ultrasound Med. 1993. Nov;12(11):659–63. doi: 10.7863/jum.1993.12.11.659 [DOI] [PubMed] [Google Scholar]
- 6.Friedberg MK, Silverman NH, Moon-Grady AJ, Tong E, Nourse J, Sorenson B, et al. Prenatal Detection of Congenital Heart Disease. J Pediatr. 2009;155(1):31.e1. doi: 10.1016/j.jpeds.2009.01.050 [DOI] [PubMed] [Google Scholar]
- 7.Garne E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol. 2001;17(5):386–91. doi: 10.1046/j.1469-0705.2001.00385.x [DOI] [PubMed] [Google Scholar]
- 8.Michelfelder EC, Cnota JF. Prenatal Diagnosis of Congenital Heart Disease in an Era of Near-Universal Ultrasound Screening: Room for Improvement. J Pediatr. 2009;155(1):9–11. doi: 10.1016/j.jpeds.2009.02.057 [DOI] [PubMed] [Google Scholar]
- 9.Pinto NM, Keenan HT, Minich LL, Puchalski MD, Heywood M, Botto LD. Barriers to prenatal detection of congenital heart disease: a population‐based study. Ultrasound Obstet Gynecol. 2012;40(4):418–25. doi: 10.1002/uog.10116 [DOI] [PubMed] [Google Scholar]
- 10.Robinson J, Simpson L, Abuhamad A. Screening For Fetal Heart Disease With Ultrasound. Clin Obstet Gynecol. 2003. Dec;46(4):890–6. doi: 10.1097/00003081-200312000-00021 [DOI] [PubMed] [Google Scholar]
- 11.Eastwood KA, Daly C, Hunter A, McCance D, Young I, Holmes V. The impact of maternal obesity on completion of fetal anomaly screening. J Perinat Med. 2017;45(9):1061–7. doi: 10.1515/jpm-2016-0048 [DOI] [PubMed] [Google Scholar]
- 12.Hunsley C, Farrell T. The influence of maternal body mass index on fetal anomaly screening. Eur J Obstet Gynecol Reprod Biol. 2014;182:181–4. doi: 10.1016/j.ejogrb.2014.09.031 [DOI] [PubMed] [Google Scholar]
- 13.Tegnander E, Eik-Nes SH. The examiner’s ultrasound experience has a significant impact on the detection rate of congenital heart defects at the second-trimester fetal examination. [DOI] [PubMed]
- 14.Lempersz C, Van Laar JO, Clur SAB, Verdurmen KM, Warmerdam GJ, Van Der Post J, et al. The standardized 12-lead fetal electrocardiogram of the healthy fetus in mid-pregnancy: A cross-sectional study. PLoS One [Internet]. 2020;15(4):1–12. Available from: doi: 10.1371/journal.pone.0232606 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sosi-Pallares D, Pileggi F, Cisneros F, Ginefra P, Portillo B, Medrano GA, et al. The mean manifest electrical axis of the ventricular activation process (AQRS) in congenital heart disease: a new approach in electrocardiographic diagnosis. Am Heart J. 1958. May;55(5):681–700. doi: 10.1016/0002-8703(58)90006-1 [DOI] [PubMed] [Google Scholar]
- 16.Brink AJ, Neill CA. The electrocardiogram in congenital heart disease; with special reference to left axis deviation. Circulation. 1955. Oct;12(4):604–11. doi: 10.1161/01.cir.12.4.604 [DOI] [PubMed] [Google Scholar]
- 17.Neill CA, Brink AJ. Left axis deviation in tricuspid atresia and single ventricle; the electrocardiogram in 36 autopsied cases. Circulation. 1955. Oct;12(4):612–9. doi: 10.1161/01.cir.12.4.612 [DOI] [PubMed] [Google Scholar]
- 18.Verdurmen KMJ, Hulsenboom ADJ, van Laar JOEH, Wijn PFF, Vullings R, Oei SG. Orientation of the electrical heart axis in mid-term pregnancy. Eur J Obstet Gynecol Reprod Biol. 2016;207(Dec. 2016):243–6. doi: 10.1016/j.ejogrb.2016.10.030 [DOI] [PubMed] [Google Scholar]
- 19.Depasquale NP. Electrocardiogram, Ventricular Gradient and Spatial Vectorcardiogram During the First Week of Life. Am J Cardiol. 1963;12:482. doi: 10.1016/0002-9149(63)90187-5 [DOI] [PubMed] [Google Scholar]
- 20.Larks SD. Estimation of the Electrical Axis of the Fetal Heart. Am J Obstet Gynecol. 1965;91:46. doi: 10.1016/0002-9378(65)90585-5 [DOI] [PubMed] [Google Scholar]
- 21.Tissot C, Singh Y, Sekarski N, Sekarski N. Echocardiographic Evaluation of Ventricular Function—For the Neonatologist and Pediatric Intensivist. 2018;6(April):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Verdurmen K, Lempersz C, Vullings R, Schroer C, Delhaas T, van Laar JOEH, et al. Normal ranges for fetal electrocardiogram values for the healthy fetus of 18–24 weeks of gestation: a prospective cohort study. BMC Pregnancy Childbirth. 2016. Aug;16(1):227. doi: 10.1186/s12884-016-1021-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lempersz C, van Laar JOEH, Clur S-AB, Verdurmen KM, Warmerdam GJ, van der Post J, et al. The standardized 12-lead fetal electrocardiogram of the healthy fetus in mid-pregnancy: A cross-sectional study. PLoS One. 2020;15(4):e0232606. doi: 10.1371/journal.pone.0232606 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Vullings R, Peters CHL, Sluijter RJ, Mischi M, Oei SG, Bergmans JWM. Dynamic segmentation and linear prediction for maternal ECG removal in antenatal abdominal recordings. Physiol Meas. 2009;30(3):291. doi: 10.1088/0967-3334/30/3/005 [DOI] [PubMed] [Google Scholar]
- 25.Vullings R, Peters CHL, Mossavat I, Oei SG, Bergmans JWM. Bayesian Approach to Patient-Tailored Vectorcardiography. IEEE Trans Biomed Eng. 2010;57(3):586–95. doi: 10.1109/TBME.2009.2033664 [DOI] [PubMed] [Google Scholar]
- 26.Prediction Intervals [Internet]. [cited 2021 Jan 4]. Available from: https://www.graphpad.com/support/faq/the-distinction-between-confidence-intervals-prediction-intervals-and-tolerance-intervals/.
- 27.Brink AJ, Neill CA, Sodi-Pallares D, Pileggi F, Cisneros F, Ginefra P, et al. The mean manifest electrical axis of the ventricular activation process (AQRS) in congenital heart disease: a new approach in electrocardiographic diagnosis. Circulation. 1955. Oct;12(4):612–9. doi: 10.1161/01.cir.12.4.612 [DOI] [PubMed] [Google Scholar]
- 28.van Laar JOEH, Warmerdam GJJ, Verdurmen KMJ, Vullings R, Peters CHL, Houterman S, et al. Fetal heart rate variability during pregnancy, obtained from non-invasive electrocardiogram recordings. Acta Obstet Gynecol Scand. 2014;93(1):93–101. doi: 10.1111/aogs.12286 [DOI] [PubMed] [Google Scholar]
- 29.Verdurmen KMJ, Hulsenboom ADJ, van Laar JOEH, Oei SG. Effect of tocolytic drugs on fetal heart rate variability: a systematic review. J Matern Fetal Neonatal Med. 2017;30(20):2387–94. doi: 10.1080/14767058.2016.1249844 [DOI] [PubMed] [Google Scholar]
- 30.Noben L, Verdurmen KMJ, Warmerdam GJJ, Vullings R, Oei SG, van Laar JOEH. The fetal electrocardiogram to detect the effects of betamethasone on fetal heart rate variability. Early Hum Dev. 2019. Mar;130:57–64. doi: 10.1016/j.earlhumdev.2019.01.011 [DOI] [PubMed] [Google Scholar]
- 31.Hall JE. Guyton and Hall Textbook of Medical Physiology. In: 13th ed. Philadelphia: Saunders Elsevier; 2016. p. 144–7. [Google Scholar]